SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-008700
Filing Date
2024-02-21
Accepted
2024-02-21 11:17:25
Documents
17
Period of Report
2024-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20022046_8k.htm   iXBRL 8-K 27848
2 EXHIBIT 99.1 ef20022046_ex99-1.htm EX-99.1 396285
6 image0.jpg GRAPHIC 7709
7 image1.jpg GRAPHIC 803
  Complete submission text file 0001140361-24-008700.txt   597629

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20240221.xsd EX-101.SCH 3875
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240221_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240221_pre.xml EX-101.PRE 16051
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20022046_8k_htm.xml XML 4072
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 24657178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)